Picture of Bioton SA logo

BIO — Bioton SA Share Price

0.000.00%
pl flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Momentum

Relative Strength (%)
1m+4.66%
3m-2.23%
6m+8.83%
1yr-20.18%
Volume Change (%)
10d/3m-70.54%
Price vs... (%)
52w High-29.09%
50d MA-2.86%
200d MA-9.96%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital2.13%
Return on Equity0.78%
Operating Margin8.34%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Bioton SA EPS forecast chart

Profile Summary

Bioton SA is a Poland-based company active in the pharmaceutical sector. The Company is engaged in research, development and wholesale trade of pharmaceutical and biotechnological products. The Company's portfolio consists of oral hypoglycemic drugs (metformin and glimepride) as well as recombinant human insulin in pharmaceutical substance form and for injections. Additionally, the Company provides advertising services. As of December 31, 2011, the Company formed a capital group and operated through its subsidiaries, including BIOTON TRADE Sp. z o.o., Mindar Holdings Ltd, Germonta Holdings Ltd, Tricel SA, SciGen Ltd and BioPartners Holdings AG, among others. On June 12, 2014, it sold a 50% stake in Copernicus Sp. z o.o.

Directors

Last Annual
December 31st, 2021
Last Interim
March 31st, 2022
Incorporated
August 2nd, 2004
Public Since
March 16th, 2005
No. of Employees
371
Sector
Biotechnology & Medical Research
Industry
Healthcare
Exchange
pl flag iconWarsaw Stock Exchange
Shares in Issue
85,864,200
Blurred out image of a map
Address
ul. Staroscinska 5, WARSZAWA, 02-516
Web
https://bioton.com/
Phone
+48 227214000
Contact
Katarzyna Sadowska
Auditors
PricewaterhouseCoopers Polska sp. z o.o. Audyt sp.k.

BIO Share Price Performance

Upcoming Events for BIO

Bioton SA Annual Shareholders Meeting

Bioton SA Annual Shareholders Meeting

Similar to BIO

Picture of Airway Medix SA logo

Airway Medix SA

pl flag iconWarsaw Stock Exchange

Picture of Blirt SA logo

Blirt SA

pl flag iconWarsaw Stock Exchange

Picture of Braster SA w restrukturyzacji logo

Braster SA w restrukturyzacji

pl flag iconWarsaw Stock Exchange

Picture of Captor Therapeutics SA logo

Captor Therapeutics SA

pl flag iconWarsaw Stock Exchange

FAQ

Or unlock with your email

Or unlock with your email